Ian Brighthope's Substack

Ian Brighthope's Substack

Share this post

Ian Brighthope's Substack
Ian Brighthope's Substack
Genetically Modified Flu Virus Trials: A Risky Experiment or a Necessary Step? Does the Doherty Institute carry insurance cover for invasive pathogens?

Genetically Modified Flu Virus Trials: A Risky Experiment or a Necessary Step? Does the Doherty Institute carry insurance cover for invasive pathogens?

I wonder how ethical scientists working in Doherty feel about this proposal.

Ian Brighthope's avatar
Ian Brighthope
Feb 14, 2025
∙ Paid
35

Share this post

Ian Brighthope's Substack
Ian Brighthope's Substack
Genetically Modified Flu Virus Trials: A Risky Experiment or a Necessary Step? Does the Doherty Institute carry insurance cover for invasive pathogens?
31
12
Share

GM Flu Trials: A Risky Experiment or a Necessary Step?

A proposal to conduct clinical trials in Australia using genetically modified (GM) influenza viruses has sparked debate among scientists and the public. The trials, spearheaded by Doherty Clinical Trials Ltd. (DCT) and under consideration by the Office of the Gene Technology Regulator (OGTR) under li…

Keep reading with a 7-day free trial

Subscribe to Ian Brighthope's Substack to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Ian Brighthope
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share